Program

Chair - Prof. Christian Buske, GermanyWelcome and Introduction: Perceptual Evolution

Prof. László Gulásci, Hungary: Reducing Budgets, Increasing Access

Prof. João Gonçalves, Portugal: The Rationale of Biosimilarity

Prof. Won Seog Kim, Korea: Clinical Evidence of Biosimilar Rituximab

Panel Discussion: Biosimilar in Oncology: Yesterday, Today and 

Interview with Prof. Won Seog Kim, MD, PhD, Sungkyunkwan University, Seoul, South Korea

 

Chair - Prof. Christian Buske, Germany: Welcome and Introduction: Perceptual Evolution from Oncoletter on Oncoletter.

Prof. László Gulásci, Hungary: Reducing Budgets, Increasing Access from Oncoletter on Oncoletter.

Prof. João Gonçalves, Portugal: The Rationale of Biosimilarity from Oncoletter on Oncoletter.

Prof. Won Seog Kim, Korea: Clinical Evidence of Biosimilar Rituximab from Oncoletter on Oncoletter.

Panel Discussion: Biosimilar in Oncology: Yesterday, Today and from Oncoletter on Oncoletter.

Interview with Prof. Won Seog Kim, MD, PhD, Sungkyunkwan University, Seoul, South Korea from Oncoletter on Oncoletter.